{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/prov/445345705"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/254544762" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/446142858"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/254544762" ] } },

    { "id" : "http://webisa.webdatacommons.org/254544762"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Subjects, who on direct questioning and physical examination, have evidence of any past or present clinically significant disease and particularly coagulation disorders, immuno mediated conditions and skin diseases and allergies, such as eczema." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "clinicaltrials.gov" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/425744722"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/254544762"] } } }
